289 related articles for article (PubMed ID: 17570480)
1. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.
Zuo T; Wang L; Morrison C; Chang X; Zhang H; Li W; Liu Y; Wang Y; Liu X; Chan MW; Liu JQ; Love R; Liu CG; Godfrey V; Shen R; Huang TH; Yang T; Park BK; Wang CY; Zheng P; Liu Y
Cell; 2007 Jun; 129(7):1275-86. PubMed ID: 17570480
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development.
Pseftogas A; Xanthopoulos K; Siasiaridis A; Poutahidis T; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
Anticancer Res; 2024 May; 44(5):1885-1894. PubMed ID: 38677721
[TBL] [Abstract][Full Text] [Related]
3. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
[TBL] [Abstract][Full Text] [Related]
4. FOXP3 expression and overall survival in breast cancer.
Merlo A; Casalini P; Carcangiu ML; Malventano C; Triulzi T; Mènard S; Tagliabue E; Balsari A
J Clin Oncol; 2009 Apr; 27(11):1746-52. PubMed ID: 19255331
[TBL] [Abstract][Full Text] [Related]
5. Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.
Wang L; Liu R; Li W; Chen C; Katoh H; Chen GY; McNally B; Lin L; Zhou P; Zuo T; Cooney KA; Liu Y; Zheng P
Cancer Cell; 2009 Oct; 16(4):336-46. PubMed ID: 19800578
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Zhang C; Xu Y; Hao Q; Wang S; Li H; Li J; Gao Y; Li M; Li W; Xue X; Wu S; Zhang Y; Zhang W
Int J Cancer; 2015 Sep; 137(6):1279-90. PubMed ID: 25683728
[TBL] [Abstract][Full Text] [Related]
7. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
[TBL] [Abstract][Full Text] [Related]
8. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
[TBL] [Abstract][Full Text] [Related]
9. FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells.
Hao Q; Zhang C; Gao Y; Wang S; Li J; Li M; Xue X; Li W; Zhang W; Zhang Y
Cell Signal; 2014 Mar; 26(3):564-9. PubMed ID: 24308961
[TBL] [Abstract][Full Text] [Related]
10. FOXP3 expression in tumor cells and implications for cancer progression.
Triulzi T; Tagliabue E; Balsari A; Casalini P
J Cell Physiol; 2013 Jan; 228(1):30-5. PubMed ID: 22674548
[TBL] [Abstract][Full Text] [Related]
11. FOXP3 as an X-linked tumor suppressor.
Wang L; Liu R; Ribick M; Zheng P; Liu Y
Discov Med; 2010 Oct; 10(53):322-8. PubMed ID: 21034673
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer.
Zhang HY; Sun H
Cancer Lett; 2010 Jan; 287(1):91-7. PubMed ID: 19628330
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 Controls an miR-146/NF-κB Negative Feedback Loop That Inhibits Apoptosis in Breast Cancer Cells.
Liu R; Liu C; Chen D; Yang WH; Liu X; Liu CG; Dugas CM; Tang F; Zheng P; Liu Y; Wang L
Cancer Res; 2015 Apr; 75(8):1703-13. PubMed ID: 25712342
[TBL] [Abstract][Full Text] [Related]
14. Chemotaxis in cancer.
Roussos ET; Condeelis JS; Patsialou A
Nat Rev Cancer; 2011 Jul; 11(8):573-87. PubMed ID: 21779009
[TBL] [Abstract][Full Text] [Related]
15. ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway.
Lin X; Fu B; Yin S; Li Z; Liu H; Zhang H; Xing N; Wang Y; Xue W; Xiong Y; Zhang S; Zhao Q; Xu S; Zhang J; Wang P; Nian W; Wang X; Wu H
iScience; 2021 Apr; 24(4):102293. PubMed ID: 33723527
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation.
Yu M; Peng Z; Qin M; Liu Y; Wang J; Zhang C; Lin J; Dong T; Wang L; Li S; Yang Y; Xu S; Guo W; Zhang X; Shi M; Peng H; Luo X; Zhang H; Zhang L; Li Y; Yang XP; Sun S
Mol Cell; 2021 Mar; 81(6):1216-1230.e9. PubMed ID: 33606996
[TBL] [Abstract][Full Text] [Related]
17. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.
Hinz S; Pagerols-Raluy L; Oberg HH; Ammerpohl O; Grüssel S; Sipos B; Grützmann R; Pilarsky C; Ungefroren H; Saeger HD; Klöppel G; Kabelitz D; Kalthoff H
Cancer Res; 2007 Sep; 67(17):8344-50. PubMed ID: 17804750
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of multimodal single-cell data.
Hao Y; Hao S; Andersen-Nissen E; Mauck WM; Zheng S; Butler A; Lee MJ; Wilk AJ; Darby C; Zager M; Hoffman P; Stoeckius M; Papalexi E; Mimitou EP; Jain J; Srivastava A; Stuart T; Fleming LM; Yeung B; Rogers AJ; McElrath JM; Blish CA; Gottardo R; Smibert P; Satija R
Cell; 2021 Jun; 184(13):3573-3587.e29. PubMed ID: 34062119
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
Ding S; Chen X; Shen K
Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
[TBL] [Abstract][Full Text] [Related]
20. Robust enumeration of cell subsets from tissue expression profiles.
Newman AM; Liu CL; Green MR; Gentles AJ; Feng W; Xu Y; Hoang CD; Diehn M; Alizadeh AA
Nat Methods; 2015 May; 12(5):453-7. PubMed ID: 25822800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
